English 
Español 
français 
العربية Search
Search
Cytarabine is mainly used to treat malignant blood disorders such as acute myelogenous leukemia and non-Hodgkin's lymphoma.
The main mechanism of cytarabine is the competitive inhibition of DNA polymerase and insertion into the DNA strand to terminate DNA activity, so it has the greatest impact on rapidly dividing cancer cells and bone marrow cells. Cytarabine is mainly used for the treatment of acute lymphocytic and non-lymphocytic leukemia induction and maintenance consolidation phase, chronic myeloid leukemia blast phase and malignant lymphoma treatment, ophthalmology for the treatment of viral keratitis and epidemic conjunctivitis. Cytarabine also has a certain effect on head and neck cancer, digestive tract cancer and lung cancer, in addition, cytarabine can inhibit the reproduction of herpes simplex virus, smallpox virus, vaccinia virus reproduction and the body's immune response.
| Item | Specifications | Results |
| Appearance | A white or almost white crystalline powder | Conform |
| Heavy Metal | ≤10ppm | Conform |
| Residue on ignition | ≤0.5% | 0.1% |
| Loss on drying | ≤1.0% | Conform |
| Purity | ≥99.0% | 99.5% |
| Product parameters | |
| Cas number: | 147-94-4 |
| Appearance: | A white or almost white crystalline powder |
| Purity: | 99% min |
| Package details: | 1kg/bag;25kg/drum or as you require |
| Brand: | Fortunachem |
Guaranteed the purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
